Kick off meeting, preclinical pharmacokinetic & pharmacological evaluations of agents being developed for cancer patients, 7/1/2016-9/30/16, HHSN261201600024I
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,603
Award facts
- Opportunity
-
- N02CM6700011 Solicitation number
- Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients Award Notice · Posted Feb 5, 2016
- Preclinical Pharmacokinetic and Pharmacological Studies Being Developed for Cancer Patients Award Notice · Posted Oct 6, 2015
- Contract value 100% obligated
- $1,603.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rochester, MN 55905, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mayo Clinic, a renowned non-profit academic medical center. The contract is for $1,603.00 and covers pre-clinical pharmacokinetic and pharmacology evaluations of cancer therapeutic agents being developed under the NCI's Experimental Therapeutics program. This work supports the transition of promising cancer treatments from the laboratory to early clinical trials.
The contract is part of a larger $9.9 million multiple-award IDIQ contract that the NCI awarded to Mayo Clinic in 2021, which enables the agency to efficiently access the institution's expertise in cancer research and drug development over a multi-year period. Mayo Clinic has a long history of providing comprehensive healthcare services, conducting cutting-edge medical research, and educating future healthcare professionals through federal contracts and grants. There is no set-aside designation for this specific award.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on July 1, 2016.
How much is contract HHSN26100001 worth?
The government has obligated $1,603 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201600024I, an indefinite delivery contract, on Pharmacokinetic and Pharmacology Evaluations for Cancer Patients.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award